112 related articles for article (PubMed ID: 25543271)
1. Valuing EQ-5D health states for Sri Lanka.
Kularatna S; Whitty JA; Johnson NW; Jayasinghe R; Scuffham PA
Qual Life Res; 2015 Jul; 24(7):1785-93. PubMed ID: 25543271
[TBL] [Abstract][Full Text] [Related]
2. Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri Lanka.
Kularatna S; Whitty JA; Johnson NW; Scuffham PA
Health Qual Life Outcomes; 2013 Sep; 11():149. PubMed ID: 24070162
[TBL] [Abstract][Full Text] [Related]
3. EQ-5D-3L derived population norms for health related quality of life in Sri Lanka.
Kularatna S; Whitty JA; Johnson NW; Jayasinghe R; Scuffham PA
PLoS One; 2014; 9(11):e108434. PubMed ID: 25365171
[TBL] [Abstract][Full Text] [Related]
4. Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L Value Sets.
Kularatna S; Chen G; Byrnes J; Scuffham PA
Value Health Reg Issues; 2017 May; 12():20-23. PubMed ID: 28648311
[TBL] [Abstract][Full Text] [Related]
5. Chinese time trade-off values for EQ-5D health states.
Liu GG; Wu H; Li M; Gao C; Luo N
Value Health; 2014 Jul; 17(5):597-604. PubMed ID: 25128053
[TBL] [Abstract][Full Text] [Related]
6. Development of an EORTC-8D utility algorithm for Sri Lanka.
Kularatna S; Whitty JA; Johnson NW; Jayasinghe R; Scuffham PA
Med Decis Making; 2015 Apr; 35(3):361-70. PubMed ID: 25403654
[TBL] [Abstract][Full Text] [Related]
7. Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran.
Goudarzi R; Sari AA; Zeraati H; Rashidian A; Mohammad K; Amini S
Value Health Reg Issues; 2019 May; 18():170-175. PubMed ID: 31096140
[TBL] [Abstract][Full Text] [Related]
8. Dutch Tariff for the Five-Level Version of EQ-5D.
M Versteegh M; M Vermeulen K; M A A Evers S; de Wit GA; Prenger R; A Stolk E
Value Health; 2016 Jun; 19(4):343-52. PubMed ID: 27325326
[TBL] [Abstract][Full Text] [Related]
9. Italian population-based values of EQ-5D health states.
Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
[TBL] [Abstract][Full Text] [Related]
10. Valuing health-related quality of life using a hybrid approach: Tunisian value set for the EQ-5D-3L.
Chemli J; Drira C; Felfel H; Roudijk B; Al Sayah F; Kouki M; Kooli A; Razgallah Khrouf M
Qual Life Res; 2021 May; 30(5):1445-1455. PubMed ID: 33447958
[TBL] [Abstract][Full Text] [Related]
11. Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study.
Santos M; Cintra MA; Monteiro AL; Santos B; Gusmão-Filho F; Andrade MV; Noronha K; Cruz LN; Camey S; Tura B; Kind P
Med Decis Making; 2016 Feb; 36(2):253-63. PubMed ID: 26492896
[TBL] [Abstract][Full Text] [Related]
12. Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states.
Luo N; Wang P; Thumboo J; Lim YW; Vrijhoef HJ
Pharmacoeconomics; 2014 May; 32(5):495-507. PubMed ID: 24519603
[TBL] [Abstract][Full Text] [Related]
13. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
[TBL] [Abstract][Full Text] [Related]
14. Time Trade-Off Value Set for EQ-5D-3L Based on a Nationally Representative Chinese Population Survey.
Zhuo L; Xu L; Ye J; Sun S; Zhang Y; Burstrom K; Chen J
Value Health; 2018 Nov; 21(11):1330-1337. PubMed ID: 30442281
[TBL] [Abstract][Full Text] [Related]
15. A comparison of health state utility values associated with oral potentially malignant disorders and oral cancer in Sri Lanka assessed using the EQ-5D-3 L and the EORTC-8D.
Kularatna S; Whitty JA; Johnson NW; Jayasinghe R; Scuffham PA
Health Qual Life Outcomes; 2016 Jul; 14():101. PubMed ID: 27402015
[TBL] [Abstract][Full Text] [Related]
16. Validity and internal consistency of EQ-5D-3L quality of life tool among pre-dialysis patients with chronic kidney disease in Sri Lanka, a lower middle-income country.
Senanayake S; Mahesh PKB; Gunawardena N; Graves N; Kularatna S
PLoS One; 2019; 14(6):e0211604. PubMed ID: 31242189
[TBL] [Abstract][Full Text] [Related]
17. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
[TBL] [Abstract][Full Text] [Related]
18. In search of a 'pan-European value set'; application for EQ-5D-3L.
Sajjad A; Versteegh MM; Santi I; Busschbach J; Simon J; Roijen LH
BMC Med Res Methodol; 2023 Jan; 23(1):13. PubMed ID: 36635625
[TBL] [Abstract][Full Text] [Related]
19. Estimating an exchange rate between the EQ-5D-3L and ASCOT.
Stevens K; Brazier J; Rowen D
Eur J Health Econ; 2018 Jun; 19(5):653-661. PubMed ID: 28623464
[TBL] [Abstract][Full Text] [Related]
20. The valuation of the EQ-5D in Portugal.
Ferreira LN; Ferreira PL; Pereira LN; Oppe M
Qual Life Res; 2014 Mar; 23(2):413-23. PubMed ID: 23748906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
